Duvelisib has marked response, survival benefit in difficult-to-treat leukemia and lymphoma

For some patients with difficult-to-treat leukemia and lymphoma, the investigational oral medicine duvelisib may significantly improve disease outcomes, according to phase III trial data published today in the journal Blood. The DUO trial studied the head-to-head comparison of duvelisib versus ofatumumab, an approved standard-of-care chemotherapy for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). According to […]

Continue reading »

Family history linked to early-onset A-fib in minorities

(HealthDay)—Probands of African or Hispanic/Latino descent with early-onset atrial fibrillation (EOAF) are more likely than European Americans to have a first-degree relative with AF, according to a study published online Sept. 21 in JAMA Network Open. Zain Alzahrani, M.D., from the University of Illinois at Chicago, and colleagues conducted a cohort study to examine the role of family history in […]

Continue reading »

Study: Improvement in glycemic parameters by adding dapagliflozin to metformin in T2D

Researchers used continuous glucose monitoring (CGM) to assess the effects of adding dapagliflozin to a regimen of either metformin or insulin in patients with type 2 diabetes (T2D) and found significant reductions in mean glucose and other glycemic factors, with greater improvements seen in patients taking metformin compared to insulin. The design and results of this trial are published in […]

Continue reading »

Media violence, impulsivity and family conflict tied to aggressive behaviors in teenagers

Teenagers exposed to TV and film violence and high levels of household conflict are at risk of engaging in aggressive behaviors, according to a new study by researchers at three U.S. universities. Especially prone to aggressive tendencies are those who also have high levels of impulsivity, the six-member research team reported in a study published online ahead of print in […]

Continue reading »

Clinical trial investigators violate EU regulations—entries in EU Register are incomplete

According to EU legislation, clinical trials must be prospectively registered in the European Union Clinical Trials Register (EUCTR) and the main results must be reported there one year after completion of the trial. The information is thus publicly available. But in fact, results are only reported for half of drug trials (49.5 percent). According to an analysis recently published in […]

Continue reading »

Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death

In the largest multi-institutional study to date, led by researchers from Penn Medicine, the team found that among patients who underwent a transcatheter aortic valve replacement (TAVR), a high number experienced severe and moderate cases of prosthesis-patient mismatch (PPM)—meaning the implanted heart valve is too small for the patient which can lead to inadequate blood flow. The team also found […]

Continue reading »

Repeat CT common in peds traumatic epidural hematoma

(HealthDay)—For children with traumatic epidural hematomas (EDHs), repeated computed tomography (CT) imaging is common, but rarely impacts management, according to a study published in the September issue of Pediatrics. Brian F. Flaherty, M.D., from the University of Utah in Salt Lake City, and colleagues conducted a retrospective cohort study involving 184 subjects aged 0 to 18 years who had a […]

Continue reading »
1 25 26 27 28 29 51